| INDUSTRY NEWS | Grant to Fund Use of Kinase Test in HER2-Positive Breast Cancer Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer. [University of North Carolina Health Care System] Press Release Collaborative Study Looks for Clues on Hard-to-Treat Breast Cancer Triple negative breast cancer is the focus of a 20-month, $8.6-million research project that aims to find new diagnostic tools and options for drugs. [EurekAlert!] Press Release NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay NanoString Technologies, Inc. announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay. [NanoString Technologies, Inc.] Press Release Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers Generex Biotechnology Corporation announced that the expertise of the Scientific Advisory Board of Antigen Express, Inc., has been expanded by the addition of two globally recognized experts in clinical trial research and immuno-therapeutic treatments of breast cancer. [Generex Biotechnology Corporation] Press Release |
|
|
|